Fluquazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H10ClF3N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 31YX4A42L4, chemically known as 2(1h)-quinazolinone, 6-chloro-4-phenyl-1-(2,2,2-trifluoroethyl)- but generally known as fluquazone, which bears US NIH Compound Identifier 219069. European Medicines Agency schedules Fluquazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07741MIG. The term FLUQUAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). FLUQUAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fluquazone under HS 29335995 and SITC 51576. As of Q4 2014, FLUQUAZONE remains the US FDA Preferred Term for this commodity. Fluquazone bears US NLM identifiers UMLS ID C1880821 and NCI Concept Code C65733. SMILES: CLC1CC2C(N(CC(F)(F)F)C(=O)NC2C2CCCCC2)CC1.